Sign in

CIK 0001705843

  • Non-accelerated filer
  • Smaller reporting company

Cibus, Inc.

Sign in to watch
Ticker
CBUS
Exchange
Nasdaq
Industry
Agricultural Chemicals
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
271967997
Phone
+1 858-450-0008
Business address
6455 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
Former names
Calyxt, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 15 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-06 Kozicz-Stankiewicz Anna Ewa Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2019-05-06 Nelson Kimberly K. Director Grant or award · Stock Option (Right to Buy) +55,000 55,000
2019-04-29 Voytas Daniel F Chief Science Officer Exercise or conversion +3,750 $3.59 $13K 96,732
2019-04-29 Voytas Daniel F Chief Science Officer Sale −3,750 $16.31 $61K 92,982
2019-04-29 Voytas Daniel F Chief Science Officer Exercise or conversion · Stock Option (Right to Buy) −3,750 204,611
2019-04-02 Blome James Chief Executive Officer Sale −2,582 $16.65 $43K 154,136
2019-04-01 Sahoo Manoj Chief Commercial Officer Sale −1,522 $17.33 $26K 66,817
2019-03-26 Blome James Chief Executive Officer Sale −2,582 $17.87 $46K 156,718
2019-03-20 Sahoo Manoj Chief Commercial Officer Sale −3,262 $18.00 $59K 68,339
2019-03-19 Sahoo Manoj Chief Commercial Officer Sale −5,068 $18.00 $91K 71,601
2019-03-19 Blome James Chief Executive Officer Sale −2,582 $17.32 $45K 159,300
2019-03-14 Ribeill Yves J Director Sale −4,980 $16.33 $81K 40,020
2019-03-13 Ribeill Yves J Director Sale −5,000 $16.08 $80K 45,000
2019-03-12 Blome James Chief Executive Officer Sale −2,582 $16.58 $43K 161,882
2019-03-12 Ribeill Yves J Director Sale −5,000 $16.76 $84K 50,000
2019-03-11 Ribeill Yves J Director Sale −5,000 $17.39 $87K 55,000
2019-02-25 Voytas Daniel F Chief Science Officer Exercise or conversion +3,977 $3.59 $14K 96,959
2019-02-25 Voytas Daniel F Chief Science Officer Sale −3,977 $16.00 $64K 92,982
2019-02-25 Voytas Daniel F Chief Science Officer Exercise or conversion · Stock Option (Right to Buy) −3,977 208,361
2019-02-08 Koschak William Chief Financial Officer Grant or award · Stock Option (Right to Buy) +180,000 180,000

Page 23 of 27 · 525 trades